Empowering appropriate antimicrobial use with rapid diagnostics.

The Consequences of Antimicrobial Misuse

According to the World Health Organization (WHO), there are no global data on the number of cases or fatalities due to highly resistant pathogens. These gaps in knowledge regarding the economic and human cost of resistant bacterial infections are due to the lack of any coordinated global surveillance system. In the U.S. alone, superbugs affect more than 2 million individuals and contribute to 99,000 deaths each year.1 In the European Union, at least 25,000 patients die every year from multidrug-resistant pathogens2; two-thirds of these are due to gram-negatives. Once confined almost exclusively to the hospital environment, superbugs such as MRSA and Clostridium difficile are now emerging in the community setting.

More people now die each year of hospital acquired infections than of AIDS, traffic accidents and the flu combined.

View Next:

Copyright © 2014 Alliance for the Prudent Use of Antibiotics (APUA), licensed to Alere Inc.